Skip to main content

Table 1 Patient demographic and clinical parameters (n = 60 in each group)

From: Efficacy and safety of remimazolam compared with propofol in hypertensive patients undergoing breast cancer surgery: a single-center, randomized, controlled study

 

Propofol group

Remimazolam group

Chi-square value, t-value, or z-value

P-value

Age, (years)

63.8 ± 11.0

62.6 ± 8.9

0.696

0.490

BMI, (kg.m− 2)

24.8 ± 2.7

24.3 ± 2.6

1.004

0.320

Baseline SBP (mmHg)

141.9 ± 12.3

138.3 ± 15.8

1.396

0.165

Baseline DBP (mmHg)

77.8 ± 10.2

78.0 ± 12.1

-0.130

0.896

Baseline MAP (mmHg)

98.7 ± 9.2

98.3 ± 8.4

0.235

0.815

Fasting time (h)

14.6 ± 3.9

14.2 ± 4.2

0.522

0.600

Preoperative rehydration volume (mL)

500 (500, 800)

500 (400, 787)

-1.444

0.150

Intraoperative fluid volume (mL)

600 (550, 700)

700 (600, 800)

-1.599

0.120

ASA physical status, n (%)

  

2.143

0.200

II

24 (40.0)

32 (53.3)

  

III

36 (60.0)

28 (46.7)

  

Education level, n (%)

  

3.789

0.140

Elementary school and below

26 (43.3)

22 (36.7)

  

Middle school

29 (48.3)

37 (61.7)

  

College and above

5 (8.3)

1 (1.7)

  

Anesthesia time, (min)

98 (84, 118)

98 (84, 117)

-0.478

0.630

  1. Notes: Data for age, BMI, and fasting time are presented as the mean ± standard deviation. Other data are presented as medians (Q1, Q3) or numbers (percentages). No statistically significant differences are observed between the groups
  2. Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; ASA, American Society of Anesthesiologists